Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers
- PMID: 18095154
- DOI: 10.1007/s10549-007-9848-5
Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers
Abstract
Germline mutations in BRCA1 or BRCA2 confer an increased lifetime risk of developing breast or ovarian cancer, but variable penetrance suggests that cancer susceptibility is influenced in part by modifier genes. Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell lines derived from healthy controls, or from cancer-affected women with a strong family history of breast and ovarian cancer carrying pathogenic mutations in BRCA1 or BRCA2, or with no BRCA1/2 mutations (BRCAX). Genes discriminating between BRCA1, BRCA2 or BRCAX and controls were stratified based on irradiation response and/or cell cycle involvement. Gene lists were aligned against genes tagged with single nucleotide polymorphisms (SNPs) determined by the Cancer Genetic Markers of Susceptibility (CGEMS) Breast Cancer Whole Genome Association Scan to be nominally associated with breast cancer risk. Irradiation responsive genes whose expression correlated with BRCA1 and/or BRCA2 mutation status were more likely to be tagged by risk-associated SNPs in the CGEMS dataset (BRCA1, P = 0.0005; BRCA2, P = 0.01). In contrast, irradiation responsive genes correlating with BRCAX status were not enriched in the CGEMS dataset. Classification of expression data by involvement in cell cycle processes did not enrich for genes tagged by risk-associated SNPs, for BRCA1, BRCA2 or BRCAX groups. Using a novel combinatorial approach, we have identified a subset of irradiation responsive genes as high priority candidate BRCA1/2 modifier genes. Similar approaches may be used to identify genes and underlying genetic risk factors that interact with exogenous stimulants to cause or modify any disease, without a priori knowledge of the pathways involved.
Similar articles
-
Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.Mol Carcinog. 2010 Jun;49(6):545-55. doi: 10.1002/mc.20618. Mol Carcinog. 2010. PMID: 20306497
-
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.Breast Cancer Res Treat. 2010 Jan;119(1):221-32. doi: 10.1007/s10549-009-0394-1. Epub 2009 Apr 16. Breast Cancer Res Treat. 2010. PMID: 19370414
-
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28. J Natl Cancer Inst. 2008. PMID: 18957670
-
Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.J Clin Oncol. 2004 Feb 15;22(4):735-42. doi: 10.1200/JCO.2004.05.055. J Clin Oncol. 2004. PMID: 14966099 Review.
-
Prioritizing candidate genetic modifiers of BRCA1 and BRCA2 using a combinatorial analysis of global expression and polymorphism association studies of breast cancer.Methods Mol Biol. 2010;653:23-34. doi: 10.1007/978-1-60761-759-4_2. Methods Mol Biol. 2010. PMID: 20721735 Review.
Cited by
-
Modulating phosphate consumption, a novel therapeutic approach for the control of cancer cell proliferation and tumorigenesis.Biochem Pharmacol. 2021 Jan;183:114305. doi: 10.1016/j.bcp.2020.114305. Epub 2020 Oct 28. Biochem Pharmacol. 2021. PMID: 33129806 Free PMC article. Review.
-
A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.Int J Mol Sci. 2020 Jul 3;21(13):4754. doi: 10.3390/ijms21134754. Int J Mol Sci. 2020. PMID: 32635403 Free PMC article.
-
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.Breast Cancer Res. 2015 Aug 16;17(1):110. doi: 10.1186/s13058-015-0625-9. Breast Cancer Res. 2015. PMID: 26275715 Free PMC article.
-
Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.Mol Genet Genomics. 2015 Jun;290(3):1141-53. doi: 10.1007/s00438-014-0983-5. Epub 2015 Jan 9. Mol Genet Genomics. 2015. PMID: 25566853
-
PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.Alzheimers Res Ther. 2014 Nov 2;6(9):70. doi: 10.1186/s13195-014-0070-5. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25478031 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous